Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
0.980
-0.002 (-0.22%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Sunshine Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
56671430
Upgrade
Market Cap Growth
-4.19%0.59%-13.95%-51.77%-52.26%480.17%
Upgrade
Enterprise Value
-4-2-6-11-2632
Upgrade
Last Close Price
0.981.233.00543.001280.0023380.00
Upgrade
PS Ratio
0.130.170.170.293.33132.55
Upgrade
PB Ratio
0.210.260.260.330.67143.04
Upgrade
P/TBV Ratio
0.230.280.290.350.69271.15
Upgrade
EV/Sales Ratio
-----137.98
Upgrade
Debt / Equity Ratio
0.040.040.040.030.048.98
Upgrade
Net Debt / Equity Ratio
-0.36-0.36-0.37-0.74-0.97-0.72
Upgrade
Net Debt / EBITDA Ratio
2.002.001.563.372.440.06
Upgrade
Net Debt / FCF Ratio
1.511.510.621.773.870.08
Upgrade
Asset Turnover
1.201.201.200.850.280.14
Upgrade
Inventory Turnover
1.941.942.853.491.561.82
Upgrade
Quick Ratio
1.951.952.153.393.4322.59
Upgrade
Current Ratio
4.174.174.114.483.9424.07
Upgrade
Return on Equity (ROE)
-25.68%-25.68%-22.97%-21.04%-244.92%-
Upgrade
Return on Assets (ROA)
-9.23%-9.23%-12.55%-10.57%-34.48%-93.90%
Upgrade
Return on Capital Employed (ROCE)
-18.90%-18.90%-24.00%-22.00%-38.90%-115.60%
Upgrade
Earnings Yield
-124.30%-99.02%-85.58%-64.63%-185.03%-41.08%
Upgrade
FCF Yield
-114.52%-91.24%-236.40%-127.05%-37.65%-6.04%
Upgrade
Buyback Yield / Dilution
-492.39%-492.39%-5371.73%---
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.